Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-class oxaborole antibiotic shows potential to treat lung infections

April 4, 2012

Studies examine effects of aleglitazar on lipoproteins and aspirin-induced renal dysfunction

April 4, 2012

Encouraging data on multikinase inhibitor support clinical development

April 3, 2012

Exenatide shows potential as a cardioprotective agent

April 3, 2012

Novel imidazopyridines identified as potential hepatitis C therapeutics

April 3, 2012

Detailed phase II data disclosed on solithromycin at ECCMID

April 3, 2012

Studies further delineate clinical efficacy of mipomersen

April 3, 2012

Trials reveal efficacy of REGN-727 in treating hypercholesterolemia

April 3, 2012

Preclinical data support entry of ABTL-0812 into the clinic

April 2, 2012

Omadacycline noninferior to linezolid in phase III trial

April 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...